Drugs / GVAX
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01952730 | Nov 2013 → Sep 2018 | colorectal cancer | Massachusetts General Hospital | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GVAX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01952730 ↗ |
| Modality | Vaccine | “investigational vaccine” NCT01952730 ↗ |
| Route | Subcutaneous | “The vaccines will be administered in two injections that will be placed underneath your skin.” NCT01952730 ↗ |